Showing results (1-10 of 248) with videos related to
Sort By:
Pageof 25
Hematology/Oncology Clinics of North America|July 10, 2021
Immunotherapy for Head and Neck CancerSumita Trivedi, Lova Sun, Charu AggarwalCancer Journal (Sudbury, Mass.)|December 10, 2020
Immunotherapy for Lung Cancer-Improving Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer With ImmunotherapyLova Sun, Charu AggarwalJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Management of Patients With <i>EGFR</i> Exon 20-Mutant Advanced Non-Small Cell Lung CancerLova Sun, Melina E Marmarelis, Charu AggarwalLung Cancer (Amsterdam, Netherlands)|March 3, 2024
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levelsLova Sun, Elizabeth A Handorf, Yunyun Zhou, et al.JTO Clinical and Research Reports|January 6, 2025
Brief Report: Not Created Equal: Survival Differences by <i>KRAS</i> Mutation Subtype in NSCLC Treated With ImmunotherapyLova Sun, Yunyun Zhou, Elizabeth A Handorf, et al.Clinical Lung Cancer|November 30, 2024
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLCMargaret Stalker, Melina Marmarelis, Corey Langer, et al.Annals of Palliative Medicine|April 6, 2015
Targeted therapy for lung cancer: present and futureCharu AggarwalImmunotherapy|September 9, 2016
DNA-based immunotherapy for HPV-associated head and neck cancerCharu AggarwalJAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.Oncotargets and Therapy|July 10, 2010
Rational use of cetuximab in the treatment of advanced non-small cell lung cancerCharu Aggarwal, Hossein BorghaeiPageof 25